ISOMURA Yasuo | Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.,
スポンサーリンク
概要
関連著者
-
Takeuchi M
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
Takeuchi Makoto
Chemistry Research Laboratories Astellas Pharmaceutical Inc.
-
TAKEUCHI Makoto
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.,
-
ISOMURA Yasuo
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.,
-
Takeuchi M
Chemistry Research Laboratories Astellas Pharmaceutical Inc.
-
Isomura Y
Yamanouchi Pharmaceutical Co. Ltd. Ibaraki Jpn
-
SHIBANUMA Tadao
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.,
-
Shibanuma Tadao
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
Shibanuma Tadao
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co.
-
池田 潔
School Of Pharmaceutical Sciences University Of Shizuoka
著作論文
- Peptide Based Interleukin-1β Converting Enzyme (ICE) Inhibitors : Synthesis, Structure Activity Relationships and Crystallographic Study of the ICE-inhibitor Complex
- Spiro-Substituted Piperidines as Neurokinin Receptor Antagonists. III. Synthesis of (±)-N-[2-(3,4-Dichlorophenyl)-4-(spiro-substituted piperidin-1'-yl)butyl]-N-methylbenzamides and Evaluation of NK_1-NK_2 Dual Antagonistic Activities
- Spiro-Substituted Piperidines as Neurokinin Receptor Antagonists. I. Design and Synthesis of (±)-N-[2-(3,4-Dichlorophenyl)-4-(spiro[isobenzofuran-1(3H), 4'-piperidin]-1'-yl)butyl]-N-methylbenzamide, YM-35375,as a New Lead Compound for Novel Neurokinin Rec
- Studies on Novel Bone Resorption Inhibitors. II. Synthesis and Pharmacological Activities of Fused Aza-heteroarylbisphosphonate Derivatives
- Selective Muscarinic Antagonists. II. Synthesis and Antimuscarinic Properties of Biphenylylcarbamate Derivatives
- Selective Muscarinic Antagonists. I. Synthesis and Antimuscarinic Properties of 4-Piperidyl Benzhydrylcarbamate Derivatives
- Spiro-Substituted Piperidines as Neurokinin Receptor Antagonists. II. Syntheses and NK_2 Receptor-Antagonistic Activities of N-[2-Aryl-4-(spiro-substituted piperidin-1'-yl)butyl]carboxamides